About: Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Maria Vittoria Dieci et al published October 2018 in Seminars in Cancer Biology

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • im Oktober 2018 veröffentlichter wissenschaftlicher Artikel (de)
  • наукова стаття, опублікована в жовтні 2018 (uk)
  • article by Maria Vittoria Dieci et al published October 2018 in Seminars in Cancer Biology (en)
publication date
publication date
language of work or name
language of work or name
author name string
author name string
  • Carsten Denkert
  • Sherene Loi
  • Nina Radosevic-Robin
  • Giancarlo Pruneri
  • Baljit Singh
  • Veerle Bossuyt
  • David Rimm
  • Frederique Penault-Llorca
  • Sunil Badve
  • Roberto Salgado
  • Torsten Nielsen
  • Giuseppe Viale
  • Timothy M D'Alfonso
  • Sybille Loibl
  • Stephan Wienert
  • Susan Fineberg
  • Seong-Rim Kim
  • Fraser Symmans
  • Nils Ternes
  • Joselyn Sanchez
  • International Immuno-Oncology Biomarker Working Group on Breast Cancer
  • Gert van den Eynden
rdfs:label
  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o (en)
  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o (nl)
skos:prefLabel
  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o (en)
  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o (nl)
name
  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o (en)
  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o (nl)
author
author
title
title
  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group o (en)
page(s)
page(s)
  • 16-25
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 29024776
published in
published in
issue
volume
issue
  • Pt 2
volume
  • 52
DOI
DOI
DOI
  • 10.1016/J.SEMCANCER.2017.10.003
is owl:sameAs of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software